Botiacrine
 | This article, Botiacrine, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
| This article, Botiacrine, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
| Clinical data | |
|---|---|
| Other names | Mo 876; DMA |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H24N2OS |
| Molar mass | 340.49 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Botiacrine (INN; developmental code name Mo 876) is a drug of the tricyclic family described as an antiparkinsonian agent which was either never marketed or was possibly marketed outside of the United States.[1][2][3][4][5] It was first described in the literature by 1965.[1] The drug is an acridine derivative and is structurally related to the tricyclic antidepressant dimetacrine.[1]
References
- ^ a b c Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 170. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
- ^ Negwer, M. (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Organic-chemical Drugs and Their Synonyms. Akad.-Verlag. p. 1768. ISBN 978-3-05-500156-7. Retrieved 20 October 2024.
- ^ Unlisted Drugs. Unlisted Drugs Committee of the Pharmaceutical Section, Science-Technology Group, Special Libraries Association. 1977. pp. 112–113. Retrieved 20 October 2024.
- ^ "BOTIACRINE". Inxight Drugs. Retrieved 20 October 2024.
- ^ Publishing, W.A.W.A. (2013). Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. William Andrew. pp. 657–658. ISBN 978-0-8155-1856-3. Retrieved 20 October 2024.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |